Scott McMeekin

Scott McMeekin

UNVERIFIED PROFILE

Are you Scott McMeekin?   Register this Author

Register author
Scott McMeekin

Scott McMeekin

Publications by authors named "Scott McMeekin"

Are you Scott McMeekin?   Register this Author

100Publications

2063Reads

45Profile Views

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.

Gynecol Oncol 2019 08 4;154(2):294-301. Epub 2019 Jun 4.

Memorial Sloan Kettering Cancer Center New York, NY and Weill Cornell Medical College, New York, NY, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.04.001DOI Listing
August 2019

The pro-inflammatory effect of obesity on high grade serous ovarian cancer.

Gynecol Oncol 2016 10 15;143(1):40-45. Epub 2016 Jul 15.

Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, 800 NE 10th Street, Oklahoma City, OK, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.07.103DOI Listing
October 2016

Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis.

Acta Radiol 2016 Sep 11;57(9):1149-55. Epub 2015 Dec 11.

School of Electrical and Computer Engineering, University of Oklahoma, Norman, Oklahoma, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0284185115620947DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5150882PMC
September 2016

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.

J Clin Oncol 2016 09 20;34(25):3062-8. Epub 2016 Jun 20.

D. Scott McMeekin and Lisa M. Landrum, University of Oklahoma Health Sciences Center, Oklahoma City, OK; David L. Tritchler, Heather A. Lankes, and Shamshad Ali, NRG Oncology Statistics and Data Management Center; Shashikant B. Lele, Roswell Park Cancer Institute, Buffalo; Michael L. Pearl, Stony Brook University Hospital, Stony Brook, NY; David E. Cohn, Floor J. Backes, and Paul J. Goodfellow, The Ohio State University; Nilsa Ramirez, Research Institute at Nationwide Children's Hospital, Columbus, OH; David G. Mutch, Matthew A. Powell, and Feng Gao, Washington University School of Medicine, St. Louis, MO; Melissa A. Geller, University of Minnesota, Minneapolis, MN; Richard Zaino, Penn State Milton S. Hersey Medical Center, Hershey, PA; Russell D. Broaddus, The University of Texas MD Anderson Cancer Center, Houston, TX; Kathleen M. Darcy, Women's Health Integrated Research Collective, Annandale, VA; and Paul A. DiSilvestro, Women and Infants Hospital of Rhode Island, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.8722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012715PMC
September 2016

Primary and acquired platinum-resistance among women with high grade serous ovarian cancer.

Gynecol Oncol 2016 08 25;142(2):225-30. Epub 2016 May 25.

Section of Gynecologic Oncology, Stephenson Cancer Center at The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.05.020DOI Listing
August 2016

Quantitative measurement of adiposity using CT images to predict the benefit of bevacizumab-based chemotherapy in epithelial ovarian cancer patients.

Oncol Lett 2016 Jul 31;12(1):680-686. Epub 2016 May 31.

School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK 73019, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907303PMC
July 2016

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.

Gynecol Oncol 2016 May 11;141(2):260-263. Epub 2016 Mar 11.

Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, New York, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844793PMC
May 2016

Initiation of a formalized precision medicine program in gynecologic oncology.

Gynecol Oncol 2016 Apr;141(1):24-8

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, 800 NE 10th Street, Oklahoma City, OK 73104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.02.024DOI Listing
April 2016

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

Authors:
W Marston Linehan Paul T Spellman Christopher J Ricketts Chad J Creighton Suzanne S Fei Caleb Davis David A Wheeler Bradley A Murray Laura Schmidt Cathy D Vocke Myron Peto Abu Amar M Al Mamun Eve Shinbrot Anurag Sethi Samira Brooks W Kimryn Rathmell Angela N Brooks Katherine A Hoadley A Gordon Robertson Denise Brooks Reanne Bowlby Sara Sadeghi Hui Shen Daniel J Weisenberger Moiz Bootwalla Stephen B Baylin Peter W Laird Andrew D Cherniack Gordon Saksena Scott Haake Jun Li Han Liang Yiling Lu Gordon B Mills Rehan Akbani Mark D M Leiserson Benjamin J Raphael Pavana Anur Donald Bottaro Laurence Albiges Nandita Barnabas Toni K Choueiri Bogdan Czerniak Andrew K Godwin A Ari Hakimi Thai H Ho James Hsieh Michael Ittmann William Y Kim Bhavani Krishnan Maria J Merino Kenna R Mills Shaw Victor E Reuter Ed Reznik Carl S Shelley Brian Shuch Sabina Signoretti Ramaprasad Srinivasan Pheroze Tamboli George Thomas Satish Tickoo Kenneth Burnett Daniel Crain Johanna Gardner Kevin Lau David Mallery Scott Morris Joseph D Paulauskis Robert J Penny Candace Shelton W Troy Shelton Mark Sherman Eric Thompson Peggy Yena Melissa T Avedon Jay Bowen Julie M Gastier-Foster Mark Gerken Kristen M Leraas Tara M Lichtenberg Nilsa C Ramirez Tracie Santos Lisa Wise Erik Zmuda John A Demchok Ina Felau Carolyn M Hutter Margi Sheth Heidi J Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean C Zenklusen Jiashan Zhang Brenda Ayala Julien Baboud Sudha Chudamani Jia Liu Laxmi Lolla Rashi Naresh Todd Pihl Qiang Sun Yunhu Wan Ye Wu Adrian Ally Miruna Balasundaram Saianand Balu Rameen Beroukhim Tom Bodenheimer Christian Buhay Yaron S N Butterfield Rebecca Carlsen Scott L Carter Hsu Chao Eric Chuah Amanda Clarke Kyle R Covington Mahmoud Dahdouli Ninad Dewal Noreen Dhalla Harsha V Doddapaneni Jennifer A Drummond Stacey B Gabriel Richard A Gibbs Ranabir Guin Walker Hale Alicia Hawes D Neil Hayes Robert A Holt Alan P Hoyle Stuart R Jefferys Steven J M Jones Corbin D Jones Divya Kalra Christie Kovar Lora Lewis Jie Li Yussanne Ma Marco A Marra Michael Mayo Shaowu Meng Matthew Meyerson Piotr A Mieczkowski Richard A Moore Donna Morton Lisle E Mose Andrew J Mungall Donna Muzny Joel S Parker Charles M Perou Jeffrey Roach Jacqueline E Schein Steven E Schumacher Yan Shi Janae V Simons Payal Sipahimalani Tara Skelly Matthew G Soloway Carrie Sougnez Angela Tam Donghui Tan Nina Thiessen Umadevi Veluvolu Min Wang Matthew D Wilkerson Tina Wong Junyuan Wu Liu Xi Jane Zhou Jason Bedford Fengju Chen Yao Fu Mark Gerstein David Haussler Katayoon Kasaian Phillip Lai Shiyun Ling Amie Radenbaugh David Van Den Berg John N Weinstein Jingchun Zhu Monique Albert Iakovina Alexopoulou Jeremiah J Andersen J Todd Auman John Bartlett Sheldon Bastacky Julie Bergsten Michael L Blute Lori Boice Roni J Bollag Jeff Boyd Erik Castle Ying-Bei Chen John C Cheville Erin Curley Benjamin Davies April DeVolk Rajiv Dhir Laura Dike John Eckman Jay Engel Jodi Harr Ronald Hrebinko Mei Huang Lori Huelsenbeck-Dill Mary Iacocca Bruce Jacobs Michael Lobis Jodi K Maranchie Scott McMeekin Jerome Myers Joel Nelson Jeremy Parfitt Anil Parwani Nicholas Petrelli Brenda Rabeno Somak Roy Andrew L Salner Joel Slaton Melissa Stanton R Houston Thompson Leigh Thorne Kelinda Tucker Paul M Weinberger Cynthia Winemiller Leigh Anne Zach Rosemary Zuna

Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.

Curr Gene Ther 2015 ;15(2):182-92

Department of Pathology, The Biomedical Research Center, Suite 1403, University of Oklahoma Health Sciences Center, 975 N.E., 10th Street, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1566523214666141224100612DOI Listing
November 2015

Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.

Gynecol Oncol 2015 Oct 1;139(1):70-6. Epub 2015 Sep 1.

Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.08.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587355PMC
October 2015

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.

J Natl Cancer Inst 2015 Sep 18;107(9). Epub 2015 Jun 18.

: Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics (ASF, LAB) and Cancer Prevention Fellowship Program, Division of Cancer Prevention (ASF), National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK (SM, JLW); Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC (WTC); Washington University School of Medicine, St. Louis, MO (DM); Division of Gynecologic Oncology, Ohio State University College of Medicine, Columbus, OH (DEC); Women and Infants Hospital/Brown University, Providence, RI (RGM); University of Minnesota, Minneapolis, MN (LSD); Memorial Sloan Kettering Cancer Center, New York, NY (RAS); Anatomic Pathology, Penn State Milton S. Hersey Medical Center, Hershey, PA (RZ); Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD (MES).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/107/9/djv158.full.pdf
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/djv158
Publisher Site
http://dx.doi.org/10.1093/jnci/djv158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836803PMC
September 2015

Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer.

Gynecol Oncol 2015 Jul 26;138(1):18-23. Epub 2015 Apr 26.

University Hospital Leuven, Leuven Cancer Institute, Department of Oncology, KU Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.04.026DOI Listing
July 2015

Role of TGF-β signaling in uterine carcinosarcoma.

Oncotarget 2015 Jun;6(16):14646-55

Department of Obstetrics and Gynecology, Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546494PMC
http://dx.doi.org/10.18632/oncotarget.3711DOI Listing
June 2015

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles.

Oncotarget 2014 Aug;5(15):6453-65

Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171643PMC
http://dx.doi.org/10.18632/oncotarget.2203DOI Listing
August 2014

The survival detriment of venous thromboembolism with epithelial ovarian cancer.

Gynecol Oncol 2014 Jul 1;134(1):73-7. Epub 2014 May 1.

University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.04.046DOI Listing
July 2014

Referrals to phase I clinical trials in a gynecologic oncology unit.

Gynecol Oncol 2014 Jan 14;132(1):231-5. Epub 2013 Sep 14.

University of Oklahoma Health Sciences Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.09.003DOI Listing
January 2014

Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors.

Gynecol Oncol 2014 Jan 9;132(1):50-4. Epub 2013 Nov 9.

Section of Gynecology Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.11.005DOI Listing
January 2014

Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?

Gynecol Oncol 2013 Sep 20;130(3):411-5. Epub 2013 Jun 20.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, 800 NE 10th Street, Oklahoma City, OK 71304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.06.018DOI Listing
September 2013

Distance traveled for treatment of cervical cancer: who travels the farthest, and does it impact outcome?

Int J Gynecol Cancer 2013 Jul;23(6):1099-103

Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2013/07000/Distance_Travel
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0b013e3182989464DOI Listing
July 2013

Enhanced Fano resonance of organic material films deposited on arrays of asymmetric split-ring resonators (A-SRRs).

Opt Express 2013 Apr;21(8):9343-52

School of Engineering, University of Glasgow, Glasgow G12 8LT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1364/OE.21.009343DOI Listing
April 2013

Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials.

Med Oncol 2013 Mar 9;30(1):435. Epub 2013 Feb 9.

Gynecological, Head and Neck Cancer Division, Department of Medical Oncology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-012-0435-1DOI Listing
March 2013

A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study.

Gynecol Oncol 2012 Nov 14;127(2):356-61. Epub 2012 Jul 14.

Department of Obstetrics and Gynecology, Gynecologic Oncology Section, University of Oklahoma, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.07.095DOI Listing
November 2012

Serum profiling to distinguish early- and late-stage ovarian cancer patients from disease-free individuals.

Cancer Invest 2012 Feb 7;30(2):189-97. Epub 2011 Dec 7.

Department of Biochemistry & Molecular Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07357907.2011.636115DOI Listing
February 2012

What should lymphadenectomy offer in early-stage endometrial cancer: lots of variables, little control.

Authors:
D Scott McMeekin

Am J Obstet Gynecol 2011 Dec 16;205(6):509-10. Epub 2011 Sep 16.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2011.09.003DOI Listing
December 2011

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer.

Gynecol Oncol 2011 Sep 12;122(3):527-31. Epub 2011 Jun 12.

University of Oklahoma Health Sciences Center, Section of Gynecology Oncology, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.05.022DOI Listing
September 2011

Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents.

Oncologist 2010 7;15(10):1026-33. Epub 2010 Oct 7.

University of Oklahoma Health Sciences Center, 4502 East 41st Street, Tulsa, Oklahoma 74135, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2010-0087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227900PMC
February 2011

Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.

Int J Clin Exp Pathol 2010 Jul 5;3(6):608-17. Epub 2010 Jul 5.

Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907123PMC
July 2010

Necessity of radical hysterectomy for endometrial cancer patients with cervical invasion.

J Korean Med Sci 2010 Apr 19;25(4):552-6. Epub 2010 Mar 19.

Department of Obstetrics and Gynecology, Seoul Metropolitan Boramae Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
https://synapse.koreamed.org/DOIx.php?id=10.3346/jkms.2010.2
Publisher Site
http://dx.doi.org/10.3346/jkms.2010.25.4.552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844596PMC
April 2010

Magnetic response of split ring resonators (SRRs) at visible frequencies.

Opt Express 2010 Feb;18(3):3210-8

Department of Electronics and Electrical Engineering, University of Glasgow, Glasgow G12 8LT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1364/OE.18.003210DOI Listing
February 2010

A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncology.

Gynecol Oncol 2009 Dec 4;115(3):443-6. Epub 2009 Oct 4.

Division of Gynecologic Oncology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Room J7-124, Dallas, TX 75390-9032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.09.004DOI Listing
December 2009

Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P.

J Clin Oncol 2009 Jul 18;27(19):3104-8. Epub 2009 May 18.

Program in Women's Oncology of Women and Infants, Hospital/Warren Alpert Medical School of Brown University, 101 Dudley St, Providence, RI 92905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.6995DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716935PMC
July 2009

Vulvar cancer in young women: demographic features and outcome evaluation.

Am J Obstet Gynecol 2009 Jun 16;200(6):645.e1-5. Epub 2009 Mar 16.

Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000293780900031
Publisher Site
http://dx.doi.org/10.1016/j.ajog.2009.01.014DOI Listing
June 2009

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.

Gynecol Oncol 2009 Feb 28;112(2):337-41. Epub 2008 Nov 28.

Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.10.009DOI Listing
February 2009

Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study.

Gynecol Oncol 2009 Jan 29;112(1):134-41. Epub 2008 Oct 29.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Oklahoma, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.09.015DOI Listing
January 2009

Asymmetric split ring resonators for optical sensing of organic materials.

Opt Express 2009 Jan;17(2):1107-15

Department of Electronics and Electrical Engineering, University of Glasgow, Glasgow, G12 8LT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1364/oe.17.001107DOI Listing
January 2009

Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

Gynecol Oncol 2008 Aug 20;110(2):133-9. Epub 2008 May 20.

University of Oklahoma Health Sciences Center, Division of Gynecologic Oncology, Oklahoma City, Oklahoma 73103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.03.008DOI Listing
August 2008

Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.

Gynecol Oncol 2008 Mar 26;108(3):584-90. Epub 2007 Dec 26.

Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, PO Box 26901, Williams Pavilion 2410, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.11.010DOI Listing
March 2008

Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.

Gynecol Oncol 2008 Mar 14;108(3):466-71. Epub 2008 Jan 14.

University of Oklahoma, Division of Gynecologic Oncology, 920 SL Young Boulevard, Oklahoma City, OK, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082580700933
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2007.11.043DOI Listing
March 2008

A phase II study of weekly docetaxel for patients with advanced or recurrent cancer of the cervix.

Gynecol Obstet Invest 2007 30;64(4):193-8. Epub 2007 Jul 30.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, State University of New York at Stony Brook, Stony Brook, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000106489DOI Listing
December 2007

A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study.

Gynecol Oncol 2007 Nov 3;107(2):274-9. Epub 2007 Aug 3.

Case Western Reserve University and Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.06.012DOI Listing
November 2007

Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era.

Gynecol Oncol 2007 Sep 31;106(3):521-5. Epub 2007 May 31.

Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Oklahoma University Health Sciences Center, PO Box 26901, WP2410, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.04.029DOI Listing
September 2007

Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma.

Gynecol Oncol 2007 Sep 11;106(3):498-501. Epub 2007 Jun 11.

University of Oklahoma Health Sciences Center, 920 SL Young Blvd, WP 2470, Oklahoma City, OK, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.04.030DOI Listing
September 2007

A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.

Gynecol Oncol 2007 Sep 27;106(3):596-603. Epub 2007 Jun 27.

University of Oklahoma, Department of Gynecologic Oncology, Health Sciences Center, OB/GYN, Oklahoma City, OK 73190, and Department of Reproductive Medicine, University Hospitals of Cleveland, OH 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.05.013DOI Listing
September 2007

Pathologic findings and outcomes for octogenarians presenting with uterine malignancy.

Gynecol Oncol 2007 Sep 5;106(3):572-8. Epub 2007 Jul 5.

University of Oklahoma Division of Gynecologic Oncology, 920 SL Young Blvd., Oklahoma City, OK 73103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.05.028DOI Listing
September 2007

Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

J Clin Oncol 2007 Jul;25(19):2811-8

Washington University School of Medicine, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.09.6735DOI Listing
July 2007

Sequence dependence of hematologic toxicity using carboplatin and topotecan for primary therapy of advanced epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.

Gynecol Oncol 2006 Nov 2;103(2):473-8. Epub 2006 May 2.

Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.03.014DOI Listing
November 2006

Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

Gynecol Oncol 2006 Feb 4;100(2):385-8. Epub 2005 Nov 4.

Division of Gynecologic Oncology, University of California Irvine Medical Center, Orange, CA 92868, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.09.009DOI Listing
February 2006

Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone.

Gynecol Oncol 2006 Feb;100(2):379-84

Department of Obstetrics and Gynecology, University of Tennessee at Memphis, 854 Jefferson Ave., Room E-102, Memphis, TN 38163, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.09.015DOI Listing
February 2006

Consolidation therapy in ovarian cancer: where do we stand?

Curr Opin Obstet Gynecol 2006 Feb;18(1):3-7

University of Oklahoma, Division of Gynecologic Oncology, Oklahoma City, Oklahoma 73104, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001703-200602000-000
Publisher Site
http://dx.doi.org/10.1097/01.gco.0000192995.20040.ffDOI Listing
February 2006

Carcinosarcoma of the ovary-a case series.

Gynecol Oncol 2006 Jan 5;100(1):128-32. Epub 2005 Oct 5.

University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.07.119DOI Listing
January 2006

Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer.

J Clin Oncol 2005 Sep;23(27):6794-5

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.08.115
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.08.115DOI Listing
September 2005

Targeted therapies for gynecologic malignancies.

Curr Treat Options Oncol 2005 Mar;6(2):121-32

University of Oklahoma- HSC, PO Box 26901, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-005-0020-3DOI Listing
March 2005

Role of pegylated liposomal doxorubicin in ovarian cancer.

Gynecol Oncol 2005 Jan;96(1):10-8

Division of Oncology, Department of Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.09.046DOI Listing
January 2005

Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer.

Gynecol Oncol 2004 Oct;95(1):157-64

Division Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.07.008DOI Listing
October 2004

Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report.

Gynecol Oncol 2004 Jan;92(1):365-7

Department of Blood and Marrow Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2003.09.004DOI Listing
January 2004

Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group study.

Cancer 2003 Oct;98(8):1664-9

Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11690DOI Listing
October 2003

Endometrial cancer: treatment of nodal metastases.

Curr Treat Options Oncol 2003 Apr;4(2):121-30

University of Oklahoma, Health Science Center, PO Box 26901, Oklahoma City, OK 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-003-0013-zDOI Listing
April 2003

Impact of individual physicians on enrollment of patients into clinical trials.

Am J Clin Oncol 2003 Apr;26(2):171-3

Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000421-200304000-00014DOI Listing
April 2003

Laparoscopic pelvic and paraaortic lymph node dissection in the obese.

Gynecol Oncol 2002 Mar;84(3):426-30

Division of Gynecologic Oncology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73190, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/gyno.2001.6548DOI Listing
March 2002